Adjuvant Radiotherapy for Pathologic T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-term Followup of a Randomized Clinical Trial

Thompson, I.; Tangen, C.; Paradelo, J.; Lucia, M.; Miller, G.; Troyer, D.; Messing, E.; Forman, J.; Chin, J.; Swanson, G.; Canby-Hagino, E.; Crawford, E.

doi:10.1016/j.juro.2008.11.032

Public

Adjuvant Radiotherapy for Pathologic T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-term Followup of a Randomized Clinical Trial

Shared by NobleBlocks on Jan 23, 2009 • 12:00 AM UTC

Authors:

I. Thompson

C. Tangen

J. Paradelo

Abstract

Purpose Extraprostatic disease will be manifest in one third of men after radical prostatectomy. We present long-term followup of a randomized clinical trial of radiotherapy to reduce risk of subsequent metastatic disease and death. Materials and Methods 431 men with pT3N0M0 prostate cancer were ran...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!